The Psychiatry Marketing Intern will integrate into the LYBALVI Brand Team and work side-by-side with our marketers to execute the 2025 LYBALVI brand plan with healthcare professionals and consumers. The Intern will own a specific set of projects to support important brand initiatives. Brand focus areas include supporting marketing material development and optimization, compiling insights from marketplace with focus on competitive promotion, optimizing tracking for free goods and material utilization, and developing brand book and centralized core claims document for harmonization across external agency partners. This will be located in our Waltham office and will work a hybrid office schedule.
Responsibilities
This is an opportunity to work in an exciting and evolving space, learn in an apprentice model from talented marketers, engage with cross-functional partners and deepen your understanding of healthcare, and make an impact. You will also be a part of a broader Alkermes intern class working across Commercial, Finance, R&D and other functions with access to special programming and networking opportunities.
Qualifications
Basic Qualifications:
- Rising Senior or Junior in 4-year undergraduate program
- Comfort using Microsoft Office tools (Outlook, PowerPoint, Excel)
- Relevant coursework in Marketing, Business, Economics, Psychology or Biology
- Strong presentation and collaboration skills
- Passion for improving our world
Preferred Qualifications:
- Relevant Major in Economics, Biology or Marketing
- Prior experience working in a business setting
- Strong academic performance
- Digital marketing experience and/or strong command of social media platforms
Working Conditions:
- Hybrid schedule: 3 days/week in Waltham office, 2 days working from home
About Us
Why join Team Alkermes?
Alkermes applies its deep neuroscience expertise to develop medicines designed to help people living with complex and difficult-to-treat psychiatric and neurological disorders. A fully-integrated, global biopharmaceutical company, headquartered in Ireland with U.S. locations in Massachusetts and Ohio, we are committed to pursuing great science, driven by deep compassion to make a real impact in the lives of patients. Alkermes has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of clinical and preclinical candidates in development for various neurological disorders, including narcolepsy.
Beyond our important mission of developing medicines to address unmet patient needs, we actively seek to foster a culture of diversity, inclusion and belonging throughout our business. We strive to ensure that all voices are respected and valued, recognizing that our diversity of thought, background and perspective makes us stronger. We are proud to have been recognized as an employer of choice by many national organizations, including being certified as a Great Place to Work in the U.S. in 2024, honored as a Healthiest Employer in both Ohio and Massachusetts in 2023, a Best Place for Working Parents in 2023, and to have received the Bell Seal at the Platinum level for Workplace Mental Health by Mental Health America for three consecutive years (2021-2023).
Alkermes, Inc. is an equal employment opportunity employer and does not discriminate against any qualified applicant or employee because of race, creed, color, age, national origin, ancestry, religion, gender, sexual orientation, gender expression and identity, disability, genetic information, veteran status, military status, application for military service or any other characteristic protected by local, state or federal law. Alkermes also complies with all work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. Alkermes is an E-Verify employer.
